| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5622790 | Alzheimer's & Dementia | 2017 | 20 Pages |
Abstract
Metabolomics identified key disease-related metabolic changes and disease-progression-related changes. Defining metabolic changes during AD disease trajectory and its relationship to clinical phenotypes provides a powerful roadmap for drug and biomarker discovery.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Jon B. Toledo, Matthias Arnold, Gabi Kastenmüller, Rui Chang, Rebecca A. Baillie, Xianlin Han, Madhav Thambisetty, Jessica D. Tenenbaum, Karsten Suhre, J. Will Thompson, Lisa St. John-Williams, Siamak MahmoudianDehkordi, Daniel M. Rotroff, John R. Jack,